Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Senft

Showing results (141-150 of 184) with videos related to

Pageof 19
Sort By:
Antibiotics (Basel, Switzerland)|November 27, 2021
Cerebrospinal Fluid Concentrations of Meropenem and Vancomycin in Ventriculitis Patients Obtained by TDM-Guided Continuous InfusionChristoph Tiede, Ute Chiriac, Daniel Dubinski, et al.
Frontiers in Immunology|April 19, 2021
Association of Isocitrate Dehydrogenase (IDH) Status With Edema to Tumor Ratio and Its Correlation With Immune Infiltration in GlioblastomaDaniel Dubinski, Sae-Yeon Won, Maximilian Rauch, et al.
Journal of Neurosurgery|July 20, 2019
To treat or not to treat? A retrospective multicenter assessment of survival in patients with IDH-mutant low-grade glioma based on adjuvant treatmentAndrej Paľa, Jan Coburger, Moritz Scherer, et al.
Blood Transfusion = Trasfusione Del Sangue|February 5, 2024
Red blood cell transfusion in patients undergoing elective primary glioblastoma resectionVanessa Neef, Sven König, Hendrik Becker, et al.
Oncotarget|May 13, 2015
Perioperative cerebral ischemia promote infiltrative recurrence in glioblastomaAnna-Luisa Thiepold, Sebastian Luger, Marlies Wagner, et al.
Neuro-Oncology|January 30, 2016
Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trialBogdana Suchorska, Michael Weller, Ghazaleh Tabatabai, et al.
Acta Neuropathologica|July 29, 2016
Brain invasion in otherwise benign meningiomas does not predict tumor recurrencePeter Baumgarten, Florian Gessler, Jens Schittenhelm, et al.
Journal of Neuro-Oncology|November 30, 2023
Treatment of very elderly glioblastoma patients ≥ 75 years of age: whom to treatPeter Baumgarten, Georg Prange, Marcel A Kamp, et al.
Journal of Clinical Medicine|April 30, 2021
Meningioma Surgery in Patients ≥70 Years of Age: Clinical Outcome and Validation of the SKALE ScoreDaniel Monden, Florian J Raimann, Vanessa Neef, et al.
Cancers|July 24, 2021
Clinical Outcome and Risk Factors of Red Blood Cell Transfusion in Patients Undergoing Elective Primary Meningioma ResectionVanessa Neef, Sven König, Daniel Monden, et al.
Pageof 19

Showing results (141-150 of 184) with videos related to

Sort By:
Pageof 19
Antibiotics (Basel, Switzerland)|November 27, 2021
Cerebrospinal Fluid Concentrations of Meropenem and Vancomycin in Ventriculitis Patients Obtained by TDM-Guided Continuous InfusionChristoph Tiede, Ute Chiriac, Daniel Dubinski, et al.
Frontiers in Immunology|April 19, 2021
Association of Isocitrate Dehydrogenase (IDH) Status With Edema to Tumor Ratio and Its Correlation With Immune Infiltration in GlioblastomaDaniel Dubinski, Sae-Yeon Won, Maximilian Rauch, et al.
Journal of Neurosurgery|July 20, 2019
To treat or not to treat? A retrospective multicenter assessment of survival in patients with IDH-mutant low-grade glioma based on adjuvant treatmentAndrej Paľa, Jan Coburger, Moritz Scherer, et al.
Blood Transfusion = Trasfusione Del Sangue|February 5, 2024
Red blood cell transfusion in patients undergoing elective primary glioblastoma resectionVanessa Neef, Sven König, Hendrik Becker, et al.
Oncotarget|May 13, 2015
Perioperative cerebral ischemia promote infiltrative recurrence in glioblastomaAnna-Luisa Thiepold, Sebastian Luger, Marlies Wagner, et al.
Neuro-Oncology|January 30, 2016
Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trialBogdana Suchorska, Michael Weller, Ghazaleh Tabatabai, et al.
Acta Neuropathologica|July 29, 2016
Brain invasion in otherwise benign meningiomas does not predict tumor recurrencePeter Baumgarten, Florian Gessler, Jens Schittenhelm, et al.
Journal of Neuro-Oncology|November 30, 2023
Treatment of very elderly glioblastoma patients ≥ 75 years of age: whom to treatPeter Baumgarten, Georg Prange, Marcel A Kamp, et al.
Journal of Clinical Medicine|April 30, 2021
Meningioma Surgery in Patients ≥70 Years of Age: Clinical Outcome and Validation of the SKALE ScoreDaniel Monden, Florian J Raimann, Vanessa Neef, et al.
Cancers|July 24, 2021
Clinical Outcome and Risk Factors of Red Blood Cell Transfusion in Patients Undergoing Elective Primary Meningioma ResectionVanessa Neef, Sven König, Daniel Monden, et al.
Pageof 19